Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-008123
Filing Date
2015-06-10
Accepted
2015-06-10 17:39:00
Documents
1
Period of Report
2015-06-09

Document Format Files

Seq Description Document Type Size
1 ZOTH ANNUAL BOD GRANT rrd425644.html 4  
1 ZOTH ANNUAL BOD GRANT rrd425644.xml 4 4328
  Complete submission text file 0001181431-15-008123.txt   5775
Mailing Address 334 CR 692 BUFFALO GAP TX 79508
Business Address
Zoth Lota S. (Reporting) CIK: 0001278219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33415 | Film No.: 15924290

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Issuer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations